subject area of
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus Academic Article
- A living WHO guideline on drugs to prevent covid-19 Academic Article
- A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial Academic Article
- ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Academic Article
- Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine: First Case Report in Canada and Review of the Literature Academic Article
- Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI Academic Article
- Antithrombotic Drugs Academic Article
- Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Academic Article
- COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine Academic Article
- Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. Academic Article
- Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Academic Article
- Drug treatments for covid-19: living systematic review and network meta-analysis Academic Article
- Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs Academic Article
- Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 Academic Article
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Academic Article
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society Academic Article
- Hydroxychloroquine attenuates cigarette smoke induced autophagic signaling in the mouse ovary Academic Article
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 Academic Article
- Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus Academic Article
- Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent Academic Article
- Interventions for cutaneous disease in systemic lupus erythematosus Academic Article
- PLATELET SUPPRESSIVE THERAPY Academic Article
- Platelet inhibitors in the treatment of thrombosis. Academic Article
- Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease Academic Article
- Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk Academic Article
- Prophylaxis against covid-19: living systematic review and network meta-analysis Academic Article
- Prophylaxis for COVID-19: a systematic review Academic Article
- Psoriasis in systemic lupus erythematosus: a single-center experience Academic Article
- Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) Academic Article
- Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update Academic Article
- The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis Academic Article
- The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19 Academic Article
- The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial Academic Article
- The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials Academic Article
- The influence of therapy on CD4+CD25highFOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study Academic Article
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus Academic Article
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Academic Article
- Trials and tribulations: so many potential treatments, so few answers Academic Article
- Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article
- Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article
- What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies? Academic Article
- Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection? Academic Article